SCHEMBL5754880

SCHEMBL5754880

COC(=O)c1cc([N+](=O)[O-])cc2c(O)nc(O)nc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.38
▸ MAPT P10636 6/20 0.37
▸ KMT2A Q03164 5/20 0.37
▸ MEN1 O00255 4/20 0.37
▸ F2 P00734 2/20 0.37
▸ PLAU P00749 2/20 0.37
▸ ELANE P08246 2/20 0.37
▸ CTRB1 P17538 2/20 0.37
▸ KLKB1 P03952 1/20 0.37
▸ RECQL P46063 1/20 0.37
▸ OPRK1 P41145 1/20 0.36
▸ PKM P14618 2/20 0.36
▸ NPC1 O15118 2/20 0.35
▸ HTT P42858 2/20 0.35
▸ LMNA P02545 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ ERN1 O75460 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5755645 0.87 KMT2A (0.40) ALDH1A1MAPTKMT2AMEN1F2
SCHEMBL5753422 0.83 MAPT (0.48) ALDH1A1MAPTKMT2AHTTSMN1; SMN2
SCHEMBL5755383 0.79 PIK3CA (0.42) ALDH1A1MAPTKMT2AMEN1KDM4E
SCHEMBL5754517 0.78 KMT2A (0.38) ALDH1A1MAPTKMT2AMEN1F2
SCHEMBL5755610 0.77 MEN1 (0.47) ALDH1A1MAPTKMT2AMEN1RECQL
SCHEMBL5756942 0.77 KMT2A (0.38) ALDH1A1MAPTKMT2AMEN1PKM
SCHEMBL5753538 0.75 MAPT (0.44) ALDH1A1MAPTKMT2AMEN1PLAU
SCHEMBL5970532 0.75 MEN1 (0.50) ALDH1A1MAPTKMT2AMEN1RECQL
SCHEMBL5756956 0.75 NQO2 (0.50) ALDH1A1MAPTKMT2AMEN1RECQL
SCHEMBL12999439 0.72 KMT2A (0.42) ALDH1A1MAPTKMT2AMEN1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218358-B1 THERAPEUTIC QUINAZOLINE COMPOUNDS ASTRAZENECA AB (SE) 2006-09-13 — — EP disclosed
EP-1218358-A1 THERAPEUTIC QUINAZOLINE COMPOUNDS AstraZeneca AB (SE) 2002-07-03 — — EP disclosed
US-6399603-B1 QUINAZOLINES; RETARDING APOPTOSIS IN CELLS; INHIBITING CLEAVAGE OF PROTEIN SUBSTRATES BY CASPASE-3; CHEMICAL AND HYDROLYTIC STABILITY ASTRAZENECA AB (SE) 2002-06-04 — — US disclosed
WO-2001021598-A1 THERAPEUTIC QUINAZOLINE COMPOUNDS ASTRAZENECA AB (SE) 2001-03-29 — — WO disclosed
Send feedback